These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17412296)

  • 41. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retracted: Epidemiological Pattern of Newly Diagnosed Children with Type 1 Diabetes Mellitus, Taif, Saudi Arabia.
    The Scientific World Journal
    ScientificWorldJournal; 2016; 2016():6736029. PubMed ID: 27631022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retracted: Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies.
    Journal of Immunology Research
    J Immunol Res; 2016; 2016():2747402. PubMed ID: 26902673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory mechanism of peptides with a repeating hydrophobic and hydrophilic residue pattern on interleukin-10.
    Ni G; Wang Y; Cummins S; Walton S; Mounsey K; Liu X; Wei MQ; Wang T
    Hum Vaccin Immunother; 2017 Mar; 13(3):518-527. PubMed ID: 27686406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10.
    Ni G; Chen S; Yang Y; Cummins SF; Zhan J; Li Z; Zhu B; Mounsey K; Walton S; Wei MQ; Wang Y; Zhou Y; Wang T; Liu X
    PLoS One; 2016; 11(4):e0153939. PubMed ID: 27100390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.
    Logsdon NJ; Eberhardt MK; Allen CE; Barry PA; Walter MR
    PLoS One; 2011; 6(11):e28127. PubMed ID: 22132227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.
    Brodeur ND; Spencer JV
    Virus Res; 2010 Nov; 153(2):265-8. PubMed ID: 20728483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-10 and the resolution of infections.
    Filippi CM; von Herrath MG
    J Pathol; 2008 Jan; 214(2):224-30. PubMed ID: 18161757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resolution of a chronic viral infection after interleukin-10 receptor blockade.
    Ejrnaes M; Filippi CM; Martinic MM; Ling EM; Togher LM; Crotty S; von Herrath MG
    J Exp Med; 2006 Oct; 203(11):2461-72. PubMed ID: 17030951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cure of chronic viral infection by neutralizing antibody treatment.
    Ejrnaes M; von Herrath MG
    Autoimmun Rev; 2007 Apr; 6(5):267-71. PubMed ID: 17412296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
    Ejrnaes M; von Herrath MG; Christen U
    Clin Dev Immunol; 2006; 13(2-4):337-47. PubMed ID: 17162375
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.